V. D. Steen and T. A. Medsger, Changes in causes of death in systemic sclerosis, Ann Rheum Dis, vol.66, pp.940-944, 1972.

M. Elhai, C. Meune, M. Boubaya, J. Avouac, E. Hachulla et al., Mapping and predicting mortality from systemic sclerosis, Ann Rheum Dis, vol.76, pp.1897-1905, 2017.

F. F. Al-dhaher, J. E. Pope, and J. M. Ouimet, Determinants of morbidity and mortality of systemic sclerosis in Canada, Semin Arthritis Rheum, vol.39, pp.269-77, 2010.

S. I. Nihtyanova, E. C. Tang, J. G. Coghlan, A. U. Wells, C. M. Black et al., Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study, QJM, vol.103, pp.109-124, 2010.

M. Rubio-rivas, C. Royo, C. P. Simeón, X. Corbella, and V. Fonollosa, Mortality and survival in systemic sclerosis: systematic review and meta-analysis, Semin Arthritis Rheum, vol.44, pp.208-227, 2014.

M. Elhai, C. Meune, J. Avouac, A. Kahan, and Y. Allanore, Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and metaanalysis of cohort studies, Rheumatology, vol.51, pp.1017-1043, 2012.

Y. Hao, M. Hudson, M. Baron, P. Carreira, W. Stevens et al., Early mortality in a multinational systemic sclerosis inception cohort, Arthritis Rheumatol, vol.69, pp.1067-77, 2017.

Y. Alamanos, N. Tsifetaki, P. Voulgari, C. Siozos, K. Tsamandouraki et al., Epidemiology of systemic sclerosis in northwest Greece, Semin Arthritis Rheum, vol.34, pp.714-734, 1981.

C. Bryan, Y. Howard, P. Brennan, C. M. Black, and A. Silman, Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population, Rheumatology, vol.35, pp.1122-1128, 1996.

J. Ioannidis, P. G. Vlachoyiannopoulos, A. Haidich, T. A. Medsger, M. Lucas et al., Mortality in systemic sclerosis: an international metaanalysis of individual patient data, Am J Med, vol.118, pp.2-10, 2005.

S. Jacobsen, P. Halberg, and S. Ullman, Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma), Rheumatology, vol.37, pp.750-755, 1998.

C. Kuo, L. See, Y. Chou, I. Tseng, W. Chang et al., Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan, Scand J Rheumatol, vol.40, pp.373-381, 2011.

P. Lee, P. Langevitz, C. Alderdice, M. Aubrey, P. Baer et al., Mortality in systemic sclerosis (scleroderma), QJM, vol.82, pp.139-187, 1992.

C. Ferri, G. Valentini, F. Cozzi, M. Sebastiani, C. Michelassi et al., Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients, Medicine (Baltimore), vol.81, pp.139-53, 2002.

L. Scussel-lonzetti, F. Joyal, J. Raynauld, A. Roussin, E. Rich et al., Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival, Medicine (Baltimore), vol.81, pp.154-67, 2002.

L. Czirjak, G. Kumanovics, C. Varju, Z. Nagy, A. Pakozdi et al., Survival and causes of death in 366 Hungarian patients with systemic sclerosis, Ann Rheum Dis, vol.67, pp.59-63, 2008.

E. Hachulla, P. Carpentier, V. Gressin, E. Diot, Y. Allanore et al., Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinerAIR-Sclerodermie study, Rheumatology, vol.48, pp.304-312, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00422549

S. Ssassi, D. Del-junco, K. Sutter, T. A. Mcnearney, J. D. Reveille et al., Clinical and genetic factors predictive of mortality in early systemic sclerosis, Arthritis Rheum, vol.61, pp.1403-1414, 2009.

B. E. Joven, R. Almodovar, L. Carmona, and P. E. Carreira, Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital, Semin Arthritis Rheum, vol.39, pp.285-93, 2010.

J. Kim, S. K. Park, K. W. Moon, E. Y. Lee, Y. J. Lee et al., The prognostic factors of systemic sclerosis for survival among Koreans, Clin Rheumatol, vol.29, pp.297-302, 2010.

P. D. Sampaio-barros, A. B. Bortoluzzo, R. G. Marangoni, L. F. Rocha, D. Rio et al., Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients, J Rheumatol, vol.39, pp.1971-1979, 2012.

A. Hoffmann-vold, Ø. Molberg, Ø. Midtvedt, T. Garen, and J. T. Gran, Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis, J Rheumatol, vol.40, pp.1127-1160, 2013.

G. Strickland, J. Pauling, C. Cavill, G. Shaddick, and N. Mchugh, Mortality in systemic sclerosis-a single centre study from the UK, Clin Rheumatol, vol.32, pp.1533-1542, 2013.

M. A. Alba, C. Velasco, C. P. Simeón, V. Fonollosa, L. Trapiella et al., Early-versus late-onset systemic sclerosis: differences in clinical presentation and outcome in 1037 patients, Medicine (Baltimore), vol.93, pp.73-81, 2014.

T. R. Cottrell, R. A. Wise, F. M. Wigley, and F. Boin, The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis, Ann Rheum Dis, vol.73, pp.1060-1066, 2014.

S. I. Nihtyanova, B. E. Schreiber, V. H. Ong, D. Rosenberg, P. Moinzadeh et al., Prediction of pulmonary complications and long-term survival in systemic sclerosis: pulmonary complications and survival in SSc, Arthritis Rheumatol, vol.66, pp.1625-1660, 2014.

A. Komócsi, A. Vorobcsuk, R. Faludi, T. Pintér, Z. Lenkey et al., The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies, Rheumatology, vol.51, pp.1027-1063, 2012.

, Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, Arthritis Rheum, vol.23, pp.581-90, 1980.

F. Van-den-hoogen, D. Khanna, J. Fransen, S. R. Johnson, M. Baron et al., 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against rheumatism collaborative initiative: ACR/EULAR classification criteria for SSc, Arthritis Rheum, vol.65, pp.2737-2784, 2013.

S. F. Nagueh, O. A. Smiseth, C. P. Appleton, B. F. Byrd, H. Dokainish et al., Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, J Am Soc Echocardiogr, vol.29, pp.277-314, 2016.

D. F. Stroup, J. A. Berlin, and S. C. Morton, Meta-analysis of observational studies in epidemiology: a proposal for reporting, JAMA, vol.283, pp.2008-2020, 2000.

G. Wells, B. Shea, D. O'connell, J. Peterson, V. Welch et al., The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis

M. Abu-shakra and P. Lee, Mortality in systemic sclerosis: a comparison with the general population, J Rheumatol, vol.22, pp.2100-2102, 1995.

M. P. Cruz-domínguez, G. García-collinot, M. A. Saavedra, D. H. Montes-cortes, R. Morales-aguilar et al., Malnutrition is an independent risk factor for mortality in Mexican patients with systemic sclerosis: a cohort study, Rheumatol Int, vol.37, pp.1101-1110, 2017.

R. Hesselstrand, A. Scheja, and A. Akesson, Mortality and causes of death in a Swedish series of systemic sclerosis patients, Ann Rheum Dis, vol.57, pp.682-688, 1998.

C. C. Mok, C. L. Kwok, L. Y. Ho, P. T. Chan, and S. F. Yip, Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China. Arthritis Rheum, vol.63, pp.1182-1191, 2011.

C. Perez-bocanegra, R. Solans-laque, C. P. Simeon-aznar, M. Campillo, V. Fonollosa-pla et al., Age-related survival and clinical features in systemic sclerosis patients older or younger than 65 at diagnosis, Rheumatology, vol.49, pp.1112-1119, 2010.

C. J. Zarafonetis, L. Dabich, D. Negri, J. J. Skovronski, E. B. Devol et al., Retrospective studies in scleroderma: effect of potassium paraaminobenzoate on survival, J Clin Epidemiol, vol.41, pp.193-205, 1988.

L. Beretta, A. Santaniello, F. Cappiello, N. V. Chawla, M. C. Vonk et al., Development of a five-year mortality model in systemic sclerosis patients by different analytical approaches, Clin Exp Rheumatol, vol.28, p.18, 2010.

L. Beretta, F. Cappiello, M. Barili, and R. Scorza, Proximal interleukin-10 gene polymorphisms in Italian patients with systemic sclerosis, Tissue Antigens, vol.69, pp.305-317, 2007.

D. Bernal-bello, J. G. De-tena, G. Castillo, A. Selva-o'callaghan, A. Callejas-moraga et al., Novel risk factors related to cancer in scleroderma, Autoimmun Rev, vol.16, pp.461-469, 2017.

V. Codullo, E. Cereda, C. Klersy, I. Cavazzana, C. Alpini et al., Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients, Rheumatology, vol.55, pp.315-324, 2016.

A. Fernández-codina, C. P. Simeón-aznar, I. Pinal-fernandez, J. Rodríguez-palomares, M. N. Pizzi et al., Cardiac involvement in systemic sclerosis: differences between clinical subsets and influence on survival, Rheumatol Int, vol.37, pp.75-84, 2017.

C. Ferri, M. Sebastiani, L. Monaco, A. Iudici, M. Giuggioli et al., Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature, Autoimmun Rev, vol.13, pp.1026-1060, 2014.

A. C. Gelber, R. L. Manno, A. A. Shah, A. Woods, E. N. Le et al., Race and association with disease manifestations and mortality in scleroderma, Medicine (Baltimore), vol.92, pp.191-205, 2013.

R. Hesselstrand, The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis, Rheumatology, vol.42, pp.534-574, 2003.

M. Hinchcliff, C. S. Desai, J. Varga, and S. J. Shah, Prevalence, progn,osis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis, Clin Exp Rheumatol, vol.30, p.30, 2012.

H. Hussein, P. Lee, C. Chau, and S. R. Johnson, The effect of male sex on survival in systemic sclerosis, J Rheumatol, vol.41, pp.2193-200, 2014.

G. Költ?, R. Faludi, D. Aradi, B. Bartos, G. Kumánovics et al., Impact of cardiac involvement on the risk of mortality among patients with systemic sclerosis: a 5-year follow-up of a single-center cohort, Clin Rheumatol, vol.33, pp.197-205, 2014.

M. D. Mayes, J. V. Lacey, J. Beebe-dimmer, B. W. Gillespie, B. Cooper et al., Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population, Arthritis Rheum, vol.48, pp.2246-55, 2003.

H. Poormoghim, E. Andalib, A. Jalali, A. Ghaderi, A. Ghorbannia et al., Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran, Rheumatol Int, vol.36, pp.925-959, 2016.

S. Ruangjutipopan, N. Kasitanon, W. Louthrenoo, W. Sukitawut, and R. Wichainun, Causes of death and poor survival prognostic factors in thai patients with systemic sclerosis, J Med Assoc Thail Chotmaihet Thangphaet, vol.85, pp.1204-1213, 2002.

C. P. Simeon, Mortality and prognostic factors in Spanish patients with systemic sclerosis, Rheumatology, vol.42, pp.71-76, 2003.

C. P. Simeón-aznar, V. Fonollosa-plá, C. Tolosa-vilella, G. Espinosa-garriga, M. Campillo-grau et al., Registry of the Spanish network for systemic sclerosis: survival, prognostic factors, and causes of death, Medicine (Baltimore), vol.94, p.1728, 2015.

V. Steen, R. T. Domsic, M. Lucas, N. Fertig, and T. A. Medsger, A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis, Arthritis Rheum, vol.64, pp.2986-94, 2012.

. Oecd, Life expectancy at birth, 2017.

J. Fransen, D. Popa-diaconu, R. Hesselstrand, P. Carreira, G. Valentini et al., Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres, Ann Rheum Dis, vol.70, pp.1788-92, 2011.

C. Bryan, C. Knight, C. M. Black, and A. J. Silman, Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit, Arthritis Rheum, vol.42, pp.2660-2665, 1999.

M. Jouvray, D. Launay, S. Dubucquoi, V. Sobanski, C. Podevin et al., Whole-body distribution and clinical association of Telangiectases in systemic sclerosis, JAMA Dermatol, vol.154, pp.796-805, 2018.

S. Sanges, J. Giovannelli, V. Sobanski, S. Morell-dubois, H. Maillard et al., Factors associated with the 6-minute walk distance in patients with systemic sclerosis, Arthritis Res Ther, vol.19, pp.279-90, 2017.

G. Lefèvre, L. Dauchet, E. Hachulla, D. Montani, V. Sobanski et al., Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis, Arthritis Rheum, vol.65, pp.2412-2435, 2013.

A. Nordin, E. Svenungsson, L. Björnådal, K. Elvin, A. Larsson et al., Troponin I and echocardiography in patients with systemic sclerosis and matched population controls, Scand J Rheumatol, vol.46, pp.226-261, 2017.

G. P. De, V. Gressin, E. Hachulla, P. Carpentier, L. Guillevin et al., Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis, Ann Rheum Dis, vol.67, pp.31-37, 2008.

A. Onishi, D. Sugiyama, S. Kumagai, and A. Morinobu, Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies, Arthritis Rheum, vol.65, pp.1913-1934, 2013.

A. J. Tyndall, B. Bannert, M. Vonk, P. Airo, F. Cozzi et al., Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database, Ann Rheum Dis, vol.69, pp.1809-1824, 2010.

A. A. Shah, A. Rosen, L. Hummers, F. Wigley, and L. Casciola-rosen, Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies, Arthritis Rheum, vol.62, pp.2787-95, 2010.

R. Bender and S. Lange, Adjusting for multiple testing-when and how?, J Clin Epidemiol, vol.54, pp.343-352, 2001.